HNRNPK and glioblastoma: We established an orthotopic GBM tumor model and demonstrated that knockdown of MGCG inhibited the development of GBM; additionally, the expression of hnRNPK and ATG2A was elevated in the clinical samples of GBM with high expression of MGCG.